Presentations by Event

EXT2514SUL (sulbactam/ETX2514) For The Treatment of Acinetobactor Baumannii Infections

Robin Isaacs, ID Week 2018

Program(s): etx2514

Restoration of Sulbactam Activity by the Novel β-lactamase Inhibitor ETX2514 Against Recent Clinical Isolates of Acinetobacter baumannii, Including Extensively Drug-Resistant (XDR) Isolates Expressing OXA-237

Sarah McLeod, ASM Microbe 2018

Program(s): etx2514

Addressing the Challenge of Gram-negative Permeation in Antibacterial Discovery

Thomas Durand-Reville, ASM Microbe 2018

Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam in Healthy Adult Subjects Poster

K.A. Rodvold (University of Illinois at Chicago), ASM Microbe 2018

Program(s): etx2514

The Novel β-lactamase Inhibitor ETX1317 Effectively Restores the Activity of Cefpodoxime Against Extended Spectrum β-lactamase (ESBL)- and Carbapenemase-Expressing Enterobacteriaceae Isolated From Recent Urinary Tract Infections, ASM Microbe, June 2018

Sarah McLeod, ASM Microbe 2018

Program(s): etx0282

Safety and Pharmacokinetics (PK) in Humans of Intravenous ETX2514, a β–lactamase Inhibitor (BLI) which Broadly Inhibits Ambler Class A, C, and D β–lactamases, ID Week, October 2017

J. Lickliter, K. Lawrence, J. O’Donnell, and R. Isaacs, ID Week 2017

Program(s): etx2514